Though significant research is underway for understanding the molecular mechanisms of NAFLD and its subsequent inflammatory and fibrotic manifestations like nonalcoholic steatohepatitis, the role of purinergic receptors has been unclear. This evidence concerns the gene P2RX7 and metabolic dysfunction-associated steatotic liver disease.